Obstetrics & Gynecology Science

Gynecologic Oncology
Serum lactate dehydrogenase is a possible predictor of platinum resistance in ovarian cancer: Asami Ikeda, Ken Yamaguchi, Hajime Yamakage, Kaoru Abiko, Noriko Satoh-Asahara, Kenji Takakura, Ikuo Konishi; Obstet Gynecol Sci. 2020;63(6):709-718. Published online September 17, 2020; DOI: https://doi.org/10.5468/ogs.20117; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Prevalence of tumor BRCA1 and BRCA2 dysfunction in unselected patients with ovarian cancer: Roshni D. Kalachand, Ciaran O’Riain, Sinead Toomey, Aoife Carr, Kirsten M. Timms, Sharon O’Toole, Stephen Madden, Mark Bates, John J. O’Leary, Noreen Gleeson, Dearbhaile O’Donnell, Liam Grogan, Oscar Breathnach, Angela Farrelly, Britta Stordal, Bryan T. Hennessy; Obstet Gynecol Sci. 2020;63(5):643-654. Published online September 2, 2020; DOI: https://doi.org/10.5468/ogs.20033; Full text PubReader ePub Crossref - TDM PDF

Associations between metabolic syndrome and gynecologic cancer: Da Yong Lee, Taek Sang Lee; Obstet Gynecol Sci. 2020;63(3):215-224. Published online March 31, 2020; DOI: https://doi.org/10.5468/ogs.2020.63.3.215; Full text PubReader ePub Crossref - TDM PDF

Prognostic value of programmed cell death ligand-1 expression in ovarian cancer: an updated meta-analysis: Jinlan Piao, Hyun Ji Lim, Maria Lee; Obstet Gynecol Sci. 2020;63(3):346-356. Published online March 24, 2020; DOI: https://doi.org/10.5468/ogs.2020.63.3.346; Full text PubReader ePub Crossref - TDM PDF

Robotic-assisted interval cytoreductive surgery in ovarian cancer: a feasibility study: Semiramis L. Carbajal-Mamani, David Schweer, Merry J. Markham, Ashwini K. Esnakula, Joseph R. Grajo, Jacqueline C. Castagno, Joel Cardenas-Goicoechea; Obstet Gynecol Sci. 2020;63(2):150-157. Published online February 10, 2020; DOI: https://doi.org/10.5468/ogs.2020.63.2.150
Cited By 4; Full text PubReader Crossref - TDM PDF Supplementary Material

Factors associated with surgical morbidity of primary debulking in epithelial ovarian cancer: Emre Günakan, Yusuf Aytaç Tohma, Mehmet Tunç, Hüseyin Akıllı, Hanifi Şahin, Ali Ayhan; Obstet Gynecol Sci. 2020;63(1):64-71. Published online December 31, 2019; DOI: https://doi.org/10.5468/ogs.2020.63.1.64
Cited By 1; Full text PubReader Crossref - TDM PDF

Potential predictors for chemotherapeutic response and prognosis in epithelial ovarian, fallopian tube and primary peritoneal cancer patients treated with platinum-based chemotherapy: Dhammapoj Jeerakornpassawat, Prapaporn Suprasert; Obstet Gynecol Sci. 2020;63(1):55-63. Published online December 23, 2019; DOI: https://doi.org/10.5468/ogs.2020.63.1.55
Cited By 1; Full text PubReader Crossref - TDM PDF

Prevalence and oncologic outcomes of BRCA1/2 mutation and variant of unknown significance in epithelial ovarian carcinoma patients in Korea: Jun Hyeong Seo, Soo Young Jeong, Myeong Seon Kim, Jun Hyeok Kang, E Sun Paik, Yoo-Young Lee, Tae-Joong Kim, Jeong-Won Lee, Byoung-Gie Kim, Duk-Soo Bae, Chel Hun Choi; Obstet Gynecol Sci. 2019;62(6):411-419. Published online October 11, 2019; DOI: https://doi.org/10.5468/ogs.2019.62.6.411
Cited By 1; Full text PubReader Crossref - TDM PDF Supplementary Material

Clinicopathologic characteristics of ovarian clear cell carcinoma in the background of endometrioma: a surveillance strategy for an early detection of malignant transformation in patients with asymptomatic endometrioma: Joo-Hyuk Son, Seokyoung Yoon, Seokyung Kim, Tae-Wook Kong, Jiheum Paek, Suk-Joon Chang, Hee-Sug Ryu; Obstet Gynecol Sci. 2019;62(1):27-34. Published online December 3, 2018; DOI: https://doi.org/10.5468/ogs.2019.62.1.27
Cited By 3; Full text PubReader Crossref - TDM PDF

Retrospective study of combination chemotherapy with etoposide and ifosfamide in patients with heavily pretreated recurrent or persistent epithelial ovarian cancer: Wonkyo Shin, Hye-joo Lee, Seong J. Yang, E sun Paik, Hyun-jin Choi, Tae-Joong Kim, Chel Hun Choi, Jeong-Won Lee, Duk-Soo Bae, Byoung-Gie Kim; Obstet Gynecol Sci. 2018;61(3):352-358. Published online May 9, 2018; DOI: https://doi.org/10.5468/ogs.2018.61.3.352
Cited By 2; Full text PubReader Crossref - TDM PDF

A rare melanoma feature with primary ovarian origin: a case report and the literature review: Algeri Paola, Rota Sonia Maria, Carlini Laura, Nicoli Elena, Caruso Orlando, Motta Teresio; Obstet Gynecol Sci. 2018;61(2):282-285. Published online February 13, 2018; DOI: https://doi.org/10.5468/ogs.2018.61.2.282
Cited By 2; Full text PubReader Crossref - TDM PDF Supplementary Material

Syndrome of inappropriate antidiuretic hormone secretion following irinotecan-cisplatin administration as a treatment for recurrent ovarian clear cell carcinoma: Do Youn Kwon, Gwan Hee Han, Roshani Ulak, Kyung Do Ki, Jong Min Lee, Seon Kyung Lee; Obstet Gynecol Sci. 2017;60(1):115-117. Published online January 19, 2017; DOI: https://doi.org/10.5468/ogs.2017.60.1.115
Cited By 4; Full text PubReader Crossref - TDM PDF

Krukenberg tumors of gastric origin versus colorectal origin: Yi Jo Jeung, Hee Jae Ok, Won Gyu Kim, Sung Han Kim, Tae Hwa Lee; Obstet Gynecol Sci. 2015;58(1):32-39. Published online January 16, 2015; DOI: https://doi.org/10.5468/ogs.2015.58.1.32
Cited By 17; Full text PubReader Crossref - TDM PDF

Ovarian metastasis from pulmonary adenocarcinoma: Young-Eun Jung, Jeong-Won Lee, Byoung-Gie Kim, Duk-Soo Bae; Obstet Gynecol Sci. 2013;56(5):341-344. Published online September 14, 2013; DOI: https://doi.org/10.5468/ogs.2013.56.5.341
Cited By 3; Full text PubReader Crossref - TDM PDF

Clinical efficacy of serum human epididymis protein 4 as a diagnostic biomarker of ovarian cancer: A pilot study: Shin Hye Chung, Soo Yoon Lee, Woong Ju, Seung Cheol Kim; Obstet Gynecol Sci. 2013;56(4):234-241. Published online July 15, 2013; DOI: https://doi.org/10.5468/ogs.2013.56.4.234
Cited By 8; Full text PubReader Crossref - TDM PDF

Search